Iodopol

Sodium Iodide, the active ingredient in Iodopol, is a radiopharmaceutical presented as an oral solution for oral use. It is employed in diagnostic imaging and therapeutic procedures involving the thyroid gland in patients requiring nuclear medicine evaluation or treatment. GNH USA supplies Iodopol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Iodopol is used in nuclear medicine for conditions that involve the thyroid gland and related diagnostic or therapeutic pathways. - Thyroid imaging: enables visualization of thyroid tissue function and morphology. - Hyperthyroidism treatment: delivers targeted radiation to reduce excess thyroid hormone production. - Thyroid cancer ablation: used post‑surgery to eliminate residual thyroid tissue or metastatic disease. - Metastatic thyroid carcinoma: provides systemic radioactive iodine therapy to target distant lesions.

Iodopol may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Nausea or vomiting: transient gastrointestinal upset. - Dry mouth: reduced salivary flow after administration. - Taste alteration: metallic or altered taste perception. - Mild thyroid pain: localized discomfort in the neck region. - Transient hypothyroidism: temporary reduction in thyroid hormone levels. - Fatigue: general feeling of tiredness.

Serious or Rare Side Effects: - Severe hypothyroidism: may require hormone replacement. - Bone marrow suppression: leading to decreased blood cell counts. - Allergic reaction: rash, itching, or anaphylaxis. - Radiation‑induced malignancy: potential long‑term cancer risk. - Salivary gland inflammation: sialadenitis causing swelling. - Pulmonary fibrosis: rare lung tissue scarring.

Before using Iodopol, consider the following safety measures. - Pregnancy assessment: avoid use in pregnant patients unless clearly indicated. - Breastfeeding guidance: discontinue breastfeeding during and after treatment as advised. - Thyroid function monitoring: check hormone levels before and after therapy. - Renal function evaluation: ensure adequate kidney function for clearance. - Iodine intake restriction: limit dietary iodine and avoid contrast agents. - Store at ambient temperature: keep in original container, protect from moisture and light.

Iodopol can interact with other substances that affect iodine metabolism or radiation exposure.

Major Interactions (Avoid): - Concurrent radioactive iodine therapy: may cause cumulative radiation toxicity. - High‑iodine diet or supplements: reduces uptake of the drug. - Thyroid hormone suppressive therapy: can interfere with intended therapeutic effect.

Moderate Interactions (Monitor Closely): - Antithyroid medications (e.g., methimazole): may alter treatment outcomes. - Lithium therapy: can affect thyroid function and iodine handling. - Certain antibiotics (e.g., amiodarone): contain iodine and may compete for uptake.